BUS FPX 4123 Assessment 6 Evaluating Current Quality Assurance Efforts
Phillip March 12, 2024 No Comments

BUS FPX 4123 Assessment 6 Evaluating Current Quality Assurance Efforts

BUS FPX 4123 Assessment 6 Evaluating Current Quality Assurance Efforts

Name

Capella university

BUS-FPX4123 Quality Assurance and Risk Management

Prof. Name

Date

National Committee on Quality Assurance & HEDIS

The National Committee on Quality Assurance (NCQA) is an independent nonprofit organization founded in 1990. It utilizes the Healthcare Effectiveness Data and Information Set (HEDIS) to hold health plans and organizations accountable for their performance (NCQA, 2021). The mission of NCQA is to enhance the quality of healthcare, achieved through quality measures. HEDIS is regarded as one of its significant accomplishments, encompassing standards across six areas of healthcare (NCQA, 2021). Health care organizations employ these measures to identify care gaps and implement improvements, aiming to make a meaningful difference in people’s lives.

The HEDIS Roadmap for success gathers information about an organization’s information management practices affecting HEDIS reporting. While it doesn’t evaluate the efficiency of an organization’s information systems, completion of the Roadmap is mandatory annually and is a requisite component of the NCQA HEDIS audit. The Roadmap furnishes auditors with crucial initial information necessary for a successful audit. All information requested in the Roadmap is vital to the audit process, requiring organizations to respond accurately and comprehensively to each question.

HEDIS Measures for Cervical Cancer Screenings (CCS)

Cervical Cancer Screenings (CCS) are categorized under the effectiveness of care in HEDIS measures. According to the American Cancer Society (2021), in 2021, an estimated 14,480 new cases of invasive cervical cancer were projected, with 4,290 women succumbing to their diagnosis. Cervical cancer has been a leading cause of cancer-related deaths among women in the U.S. since cervical cancer screening measures were initiated in 1999. In 2013, these measurement guidelines were revised to align with the recommendations of the U.S. Preventive Services Task Force (USPSTF) to reduce new diagnoses and deaths (NCQA, 2020).

BUS FPX 4123 Assessment 6 Evaluating Current Quality Assurance Efforts

Cervical Cancer Screening, primarily conducted via Pap tests, detects precancerous and abnormal cells, aiding in early cancer detection. USPSTF recommends cytology screening every three years for women aged 21 to 29, and for women aged 30 to 65, the same screening along with high-risk human papillomavirus (hrHPV) screening every five years (USPSTF, 2018). These additional measures have demonstrated efficacy in decreasing deaths attributed to invasive cervical cancers.

Benefits of Quality

Quality programs like HEDIS offer numerous benefits to patients, communities, and organizations. Implementing HEDIS measures is crucial for closing care gaps and has resulted in reduced death rates associated with cervical cancer when adhered to as recommended. For patients, early detection through screening can lead to less invasive and costly treatments. Surgical interventions for precancerous lesions are generally less expensive than treatments for invasive cancers. Additionally, more frequent screenings reduce the risk of recurrence of invasive cervical cancer, further lowering healthcare costs (CDC, 2021).

Healthcare organizations benefit from improved health outcomes associated with smaller care gaps, which positively reflect on the organization’s reputation.

References

American Cancer Society. (2021, January 12). Cervical Cancer Statistics | Key Facts About Cervical Cancer. https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html

CDC. (2021, August 18). Cost-Effectiveness of Cervical Cancer Interventions | Power of Prevention. National Center for Chronic Disease Prevention and Health Promotion. https://www.cdc.gov/chronicdisease/programs-impact/pop/cervical-cancer.htm

National Committee for Quality Assurance (NCQA). (2021, September 16). About NCQA. NCQA. https://www.ncqa.org/about-ncqa/

National Committee for Quality Assurance (NCQA). (2020, December 28). Cervical Cancer Screening. https://www.ncqa.org/hedis/measures/cervical-cancer-screening/

USPSTF. (2018, August 21). Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce. U.S. Preventive Services Task Force. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening

BUS FPX 4123 Assessment 6 Evaluating Current Quality Assurance Efforts